TCGCX
Price
$17.99
Change
+$0.24 (+1.35%)
Updated
Apr 11 closing price
Net Assets
190.61M
VMGIX
Price
$91.73
Change
+$1.69 (+1.88%)
Updated
Apr 11 closing price
Net Assets
27.18B
Ad is loading...

TCGCX vs VMGIX

Header iconTCGCX vs VMGIX Comparison
Open Charts TCGCX vs VMGIXBanner chart's image
Thornburg Small/Mid Cap Growth C
Price$17.99
Change+$0.24 (+1.35%)
VolumeN/A
Net Assets190.61M
Vanguard Mid-Cap Growth Index Investor
Price$91.73
Change+$1.69 (+1.88%)
VolumeN/A
Net Assets27.18B
TCGCX vs VMGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TCGCX vs. VMGIX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCGCX is a Buy and VMGIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 27.2B vs. TCGCX (191M). VMGIX pays higher dividends than TCGCX: VMGIX (0.59) vs TCGCX (0.00). TCGCX was incepted earlier than VMGIX: TCGCX (24 years) vs VMGIX (19 years). TCGCX (3.12) is less costly to investors than VMGIX (0.19). TCGCX is a more actively managed with annual turnover of: 57.56 vs. VMGIX (14.00). VMGIX has a lower initial minimum investment than TCGCX: VMGIX (3000) vs TCGCX (5000). VMGIX annual gain was more profitable for investors over the last year : -1.20 vs. TCGCX (-14.05). VMGIX return over 5 years is better than : 66.25 vs. TCGCX (-40.03).
TCGCXVMGIXTCGCX / VMGIX
Total Expense Ratio2.340.191,232%
Annual Report Gross Expense Ratio3.120.191,642%
Fund Existence24 years19 years-
Gain YTD-19.037-9.786195%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets191M27.2B1%
Annual Yield % from dividends0.000.59-
Returns for 1 year-14.05-1.201,171%
Returns for 3 years-7.797.64-102%
Returns for 5 years-40.0366.25-60%
Returns for 10 years-30.22113.20-27%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSHA1.250.08
+6.41%
Taysha Gene Therapies
SIDU1.380.08
+6.15%
Sidus Space
XYL109.061.38
+1.28%
Xylem
GB7.380.03
+0.41%
Global Blue Group Holding AG
UMBF86.40-1.74
-1.97%
UMB Financial Corp